Clinical Trials Browser

Phase 2/3 × INDUSTRY × Hemangioma, Capillary × Clear all

NCT06677853 2024-11-07

Timolol Maleate Gel for the Treatment of Infantile Hemangioma

Phase 2/3 Completed

Hemangioma, Capillary